neuroLAB

Our advanced technology and software allow you to generate a comprehensive individual profile of the patient's electrophysiological activity through quantitative EEG/brain mapping. 

The QEEG assessment is a powerful tool that uncovers neuromarkers and EEG phenotypes associated with a range of psychiatric conditions.

Creating electrophysiological test reports using neurocare' s DTP: QEEG

This test battery enables you to conduct various QEEG/Brain mapping tests, including:

• resting EEG - eyes open
• resting EEG - eyes closed

neuroLAB offers a variety of technical advantages over other systems currently on the market, e.g.

• cloud-based
• validated data base
• replicated studies on gender-specific biomarkers
• standardized procedures in terms of technique and assessment
• technique: wide band EEG / ERP database
• 25 EEG channels
• true DC - 100 Hz recording
• no multiplexing on amplifier 

With the neuroLAB method, you have the ability to customize therapy based on the unique needs of each patient, leading to improved treatment outcomes. By analyzing electrophysiological markers, you gain valuable insights into the most effective form of therapy and therapy protocol for the individual. This method is applicable in various scenarios, including personalized medicine, selecting the right protocol for non-invasive brain stimulation techniques (such as TMS/rTMS and tDCS), choosing an appropriate neurofeedback protocol, and applied brain research. This approach is suitable for:

• personalized medicine,
• choosing the right protocol for non-invasive brain stimulation techniques (e.g. TMS/rTMS, tDCS, ECT),
• the choice of an appropriate neurofeedback protocol,
• applied brain research.
  
  

neuroLAB supports your clinical work.

Once the QEEG tests are completed, all the collected data is analysed on cloud, and a detailed report is generated for the clinician to download. This process saves clinicians' valuable time and streamlines their manual evaluation. 

For those interested in utilizing neuroLAB for a stratified drug selection in MDD to enhance remission rates, we invite you to attend our academy workshops. Our experts will guide you in determining the most suitable medication for your patient.

Electroencephalography (EEG) 

Begin by reviewing the EEG report, which provides important information about the patient's demographics and medical history. This includes details about their physical, medical, and psychological background, as well as any substance use, experiences with depression, anxiety, and stress, emotional intelligence, and sleep history. Please note that any confidential information, such as traumatic experiences, will be appropriately redacted. Take the time to carefully examine the raw EEG in the PDF for any abnormalities, interictal discharges, and assess the overall data quality.

Quantatitve Electroencephalography (QEEG) 

neuroLAB QEEG report guides clinician interpretation through various SOPs:

• The initial pages provide scalp maps of absolute and relative power during eyes open (EO) followed by eyes closed (EC).

• The review further contains the alpha asymmetry calculated at F3 and F4. This biomarker has the potential to predict the effectiveness of medication treatments.

• The theta beta ratios during EO and EC is shown in a table and calculated for the channels Fz, Cz and Pz.

• A score 1 - 10 is showing the individual marker for selecting the appropriate neurofeedback protocol.

• Further, the power spectra are displayed for the channels in the midline during EO and EC.

• An individual alpha peak frequency is calculated.

• The quality of the recorded EEG is shown in rejected epochs.